Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients (pts) with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
Presenter
Speaker
N. Shore, Myrtle Beach (US)
Event
35th Annual EAU Congress - Virtual (EAU20V)
Date – Time -
Location
18 July 2020, 08:30
-
09:05,
Virtual room 1
Session
Game changing session -
Game changing session 2